These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 8459055

  • 1. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK, Torres FW, Garabedian HD, Werner W, Jang IK, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB.
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [Abstract] [Full Text] [Related]

  • 2. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
    Mombelli G, Marchetti O, Haeberli A, Straub PW.
    Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
    [Abstract] [Full Text] [Related]

  • 3. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
    Duval N, Lunven C, O'Brien DP, Grosset A, O'Connor SE, Berry CN.
    Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
    [Abstract] [Full Text] [Related]

  • 4. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 5. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [Abstract] [Full Text] [Related]

  • 6. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
    Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM.
    Circulation; 1995 Apr 01; 91(7):1929-35. PubMed ID: 7895349
    [Abstract] [Full Text] [Related]

  • 7. Accelerated thrombin generation during anticoagulation in patients with unstable angina pectoris.
    Garabedian HD, Gold HK, Newell JB, Collen D, Hagstrom JN, Bovill EG.
    Blood; 1994 Feb 15; 83(4):1155. PubMed ID: 8111056
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?
    Willerson JT, Casscells W.
    J Am Coll Cardiol; 1993 Apr 15; 21(5):1048-51. PubMed ID: 8459056
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
    Linder R, Oldgren J, Egberg N, Grip L, Larson G, Siegbahn A, Wallentin L.
    Eur Heart J; 1999 Apr 15; 20(7):506-18. PubMed ID: 10365287
    [Abstract] [Full Text] [Related]

  • 13. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L, Blombäck M, Egberg N, Olsson A, Svane B, Velander M.
    Eur Heart J; 1997 Mar 15; 18(3):443-9. PubMed ID: 9076381
    [Abstract] [Full Text] [Related]

  • 14. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK, Sun L, Chesebro JH, Fuster V, Harrington RA, Schwartz D, Gallo P, Matos D, Topol EJ.
    Circulation; 1996 Nov 15; 94(10):2389-95. PubMed ID: 8921778
    [Abstract] [Full Text] [Related]

  • 15. Combined administration of aspirin and a specific thrombin inhibitor in man.
    Clarke RJ, Mayo G, FitzGerald GA, Fitzgerald DJ.
    Circulation; 1991 May 15; 83(5):1510-8. PubMed ID: 2022012
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
    Oldgren J, Linder R, Grip L, Siegbahn A, Wallentin L.
    Eur Heart J; 1999 Nov 15; 20(22):1657-66. PubMed ID: 10543929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.